Skip to main content

Table 1 The expressional alterations of mutated genes

From: Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters

GeneFold ChangeP-value
KRAS1.091.5E-16
SMAD40.928.4E-4
SMARCA40.861.2E-4
STK110.923.1E-7
EGFR1.243.0E-13
KEAP11.044.2E-7
TP530.962.1E-3
RB10.932.9E-4
RBM100.795.5E-12
COL11A11.261.4E-2
NF10.943.4E-3
SETD20.971.2E-2
CDKN2A1.939.8E-7
ARID1A1.000.85
B2M0.960.26
BRAF1.020.32
TCEAL51.060.97
ZFP36L11.040.15
MGA0.950.097
ZNF6790.930.16
  1. Note: Fold change: examine the fold change in mRNA expression level of one gene between samples with mutated and wild type gene status; P-value: Wilcox-test, unpaired, two sided